The healthcare giant has been investing heavily in its future growth.

Pfizer is ramping up its fight to keep Danish drugmaker Novo Nordisk from spoiling its acquisition of an anti-obesity biotech, launching a legal campaign that paints Novo as an interfering European ...

NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind ...

Andrew Baum, a former Citi analyst, has left his role as Pfizer's executive vice president and chief strategy and innovation ...

U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss ...

GROTON -- Pfizer Inc. plans to ride a pipeline of new drugs and its leading position in the pharmaceutical industry to top last year's performance for shareholders, company leaders said at Pfizer's ...

For the past 7 years, pharmaceuticals that work as glucagon-like peptide 1 (GLP-1) receptor agonists have dominated the weight-loss and diabetes markets. These drugs, currently so ...

Pfizer's shares have rebounded, but is AbbVie still a better buy among pharmaceutical stocks?

The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year Pfizer revised its revenue expectations for 2025 and detailed its outlook for ...